Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression
Interleukin-35 (IL-35) is an immune suppressive cytokine produced by T-cells. Here, the authors show that IL-35 is overexpressed by human pancreatic cancer cells and show, in a mouse model, that IL-35 promotes metastasis in an autocrine/paracrine manner via induction of ICAM-1 expression.
Saved in:
Main Authors: | Chongbiao Huang, Na Li, Zengxun Li, Antao Chang, Yanan Chen, Tiansuo Zhao, Yang Li, Xiuchao Wang, Wei Zhang, Zhimin Wang, Lin Luo, Jingjing Shi, Shengyu Yang, He Ren, Jihui Hao |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/05647a54a54d4a00b761a25ce2b1a8aa |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
by: Adama Sidibe, et al.
Published: (2018) -
Interleukin (IL)-35 is raising our expectations
by: NING-WEI,ZHAO
Published: (2010) -
ICAM-1-carrying targeted nano contrast agent for evaluating inflammatory injury in rabbits with atherosclerosis
by: Ping Li, et al.
Published: (2021) -
Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesis.
by: Kang-Ling Liao, et al.
Published: (2014) -
Metastasis inhibition in breast cancer by targeting cancer cell extravasation
by: Cominetti MR, et al.
Published: (2019)